MODEL VERDICT
Integra LifeSciences Holdings Corporation (IART)
Relative Valuation•Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
Each row records the model's monthly assessment. High Conviction = the model detected notable undervaluation vs peers. Neutral = no notable divergence was found. The return column shows the actual price change over 90 days for reference. This is a quantitative observation log — not investment advice.
| Date | Assessment | Score | Price | Status | 90d Fwd Return |
|---|---|---|---|---|---|
| May 1, 2026 | MODERATE | 0.65 | $10.95 | CURRENT | — |
| Apr 24, 2026 | MODERATE | 0.65 | $10.57 | CURRENT | — |
| Apr 17, 2026 | MODERATE | 0.65 | $11.14 | CURRENT | — |
| Apr 16, 2026 | MODERATE | 0.65 | $11.03 | CURRENT | — |
| Apr 10, 2026 | MODERATE | 0.67 | $9.90 | CURRENT | — |
Historical model observations for research purposes only. Past quantitative patterns do not predict future results. Not a recommendation to buy, sell, or hold any security.
| Methodology | Fair Value | vs Current | Weight | Quality | Status |
|---|---|---|---|---|---|
| Forward P/E 7 analyst estimates | $76.22 | +596.1% | 20% | A- | Analyst Est. |
| Price / Free Cash Flow 7 industry peers | $16.30 | +48.9% | 15% | B+ | Peer Data |
| EV/FCF 7 industry peers | $16.79 | +53.3% | 7% | B | Model Driven |
| EV To Revenue 11 industry peers | $90.71 | +728.4% | 4% | B | Data |
| Price / Sales 11 industry peers | $87.56 | +699.6% | 3% | B | Model Driven |
| FCF Yield 8 industry peers | $17.29 | +57.9% | 1% | B | Data |
| Weighted Output Blended model output | $47.49 | +333.7% | 100% | 68 | SIGNIFICANTLY UNDERVALUED |
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
| Multiple | Avg | Median | Min | Max | Std |
|---|---|---|---|---|---|
| P/E Ratio | 50.69 | 41.35 | 25.96 | 100.48 | 29.43 |
| EV/EBIT | 42.41 | 41.07 | 22.23 | 66.51 | 16.65 |
| EV/EBITDA | 22.51 | 21.15 | 16.27 | 31.00 | 4.98 |
| P/FCF | 38.79 | 39.54 | 18.92 | 69.96 | 19.22 |
| P/FFO | 19.98 | 18.93 | 13.08 | 31.57 | 6.46 |
| P/AFFO | 35.85 | 28.70 | 18.39 | 59.94 | 17.59 |
| P/B Ratio | 2.49 | 2.60 | 0.91 | 3.65 | 1.14 |
| P/S Ratio | 2.57 | 3.01 | 0.58 | 4.03 | 1.32 |
Based on our peer multiples analysis with 15 valuation metrics, the model estimates IART's fair value at $47.49 vs the current price of $10.95, implying +333.7% upside potential. Model verdict: Significantly Undervalued. Confidence: 68/100. This is a quantitative estimate, not a recommendation.
The blended fair value of $47.49 is calculated using four lenses: industry median multiples (40%), historical multiples (30%), forward estimates (20%), and quality-adjusted multiples (10%). Monte Carlo simulation (10,000 iterations) gives a range of $40.57 (P10) to $61.55 (P90), with a median of $50.90.
IART's current P/E of -1.6x compares to the industry median of 29.0x (6 peers in the group). This represents a -105.6% discount to the industry. The historical average P/E is 50.7x over 5 years. Signal: Deep Discount.
26 analysts cover IART with a consensus rating of Buy. The consensus price target is $12.00 (range: $12.00 — $12.00), implying +9.6% upside from the current price. Grade breakdown: Strong Buy (0), Buy (11), Hold (10), Sell (5), Strong Sell (0).
The model confidence score is 68/100, based on: data completeness (15), peer quality (25), historical depth (20), earnings stability (4), and model agreement (4). Cyclicality penalty: -0 points. The model shows moderate agreement across inputs.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk data is not available for IART.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.